Laura F Newell, MD1, Shernan G. Holtan, MD2, Jason Rosenzweig, Ph.D.3*, Jane Yates4,5*, Michael Garbati, PhD, BS4*, R. K. Rathbun4*, Winifred Keeble, BS4*, Jeffrey W. Tyner, PhD6, Irina Burd, MD, PhD3* and Grover C. Bagby, M.D.7,8
1Knight Cancer Institute, Center for Hematologic Malignancies, Oregon Health & Science University, Portland, OR
2Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
3Department of Obstetrics and Gynecology, Johns Hopkins University, Baltimore, MD
4Oregon Health & Science University, Portland, OR
5Portland Veterans Affairs Medical Center, Portland, OR
6Knight Cancer Institute, Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR
7Portland VA Medical Center, Portland, OR
8Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR